OPSONIX
Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from circulating blood, offering a new broad-spectrum approach to transform the treatment of blood-borne infectious diseases, including sepsis.
OPSONIX
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.opsonixbio.com
Total Employee:
1+
Status:
Active
Contact:
617-444-8644
Email Addresses:
[email protected]
Total Funding:
9.25 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
Baxter Ventures
Baxter Ventures investment in Series A - Opsonix
More informations about "Opsonix"
Opsonix - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 617-444-8644 Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture …See details»
Opsonix Company Profile 2024: Valuation, Funding & Investors
Opsonix General Information Description. Developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis. The company's pathogen …See details»
Opsonix - Overview, News & Similar companies | ZoomInfo.com
Opsonix contact info: Phone number: (508) 351-2902 Website: www.opsonixbio.com What does Opsonix do? Opsonix is developing pathogen-extracting therapies to transform the treatment …See details»
Harvard's Wyss Institute… | Harvard Office of …
By Benjamin Boettner, Wyss Institute. Today the Wyss Institute for Biologically Inspired Engineering at Harvard University unveiled the launch of its startup company Opsonix Inc. The announcement follows a worldwide exclusive …See details»
Opsonix, Inc.: Contact Details and Business Profile - RocketReach
Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from …See details»
Opsonix - Tech Company Profile - Gaebler.com Venture Capital …
Www.opsonixbio.com. Email Address [email protected] Company Background Information. Overview. Opsonix is developing and commercializing a pathogen-extracting therapy that uses …See details»
Opsonix, Inc. - Company Information, Competitors, News & FAQs
Find useful insights on Opsonix, Inc.'s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Opsonix, Inc..See details»
Opsonix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Opsonix, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Opsonix’s Competitors, Revenue, Number of Employees, Funding …
Opsonix’s Profile, Revenue and Employees. Opsonix develops pathogen-extracting therapy for the treatment of sepsis. Opsonix’s primary competitors include ExThera Medical, …See details»
Opsonix, Inc. Asset Profile | Preqin
Opsonix, Inc. is based in Cambridge, US, and develops pathogen-extracting therapies for the treatment of sepsis and other blood-borne infectious diseases.See details»
Opsonix - VentureRadar
Similar Companies: Xtant Medical USA n/a Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets class-leading regenerative medicine products and …See details»
www.opsonixbio.com
Www.opsonixbio.comSee details»
Opsonix is Launched to Develop Pathogen-Extracting Therapies …
Oct 8, 2015 For more information, visit www.opsonixbio.com. The securities offered will not be or have not been registered under the Securities Act of 1933, as amended, and may not be …See details»
Wyss Institute startup, Opsonix Inc., honored with prestigious …
May 15, 2017 Opsonix, Inc., a startup launched from the Wyss Institute in 2015, has been selected to receive the prestigious 2017 Spinoff Award from the non-profit organization …See details»
Opsonix is Launched to Develop Pathogen-Extracting Therapies …
Oct 8, 2015 Opsonix's core technology is based on proprietary pathogen-capture proteins. Its lead molecule is a recombinant human protein derived from mannose binding lectin (MBL) …See details»
Wyss Institute launches startup to commercialize new sepsis therapy
Oct 8, 2015 The Wyss Institute has unveiled the launch of its startup company Opsonix Inc. The announcement follows a worldwide exclusive licensing agreement between Harvard s Office of …See details»
Opsonix picks up $8 mln Series A - venturecapitaljournal.com
Oct 9, 2015 Cambridge, Massachusetts-based Opsonix, a developer of pathogen-extracting treatments focused on treating blood borne infectious diseases, has launched with $8 million …See details»
Wyss Institute Launches Opsonix To Commercialize Its Pathogen ...
Oct 8, 2015 <p>The Wyss Institute for Biologically Inspired Engineering at Harvard University has unveiled the launch of its start-up company Opsonix Inc. The announcement follows a …See details»
Opsonix is Launched to Develop Pathogen-Extracting Therapy
DRUG DEVELOPMENT & DELIVERY 170 Changebridge Road Suite C5-4 Montville, NJ 07045 Tel: (973) 299-1200 Fax: (973) 299-7937See details»
Wyss Institute Launches Opsonix to Commercialize its Pathogen ...
Oct 8, 2015 The new startup company is seeking to develop an extracorporeal medical device that removes infectious pathogens and toxins from circulating blood of sepsis patients.See details»